手法淋巴引流联合肌内效贴治疗卒中后肩手综合征:西南地区随机对照试验方案
主要结局为干预4周时视觉模拟评分疼痛强度和患侧与健侧上肢体积差,次要结局包括上肢运动功能、日常生活活动能力、关节活动度和生活质量,并在基线、4周、治疗后3个月和6个月随访评估。
要点
- 该方案探索手法淋巴引流联合肌内效贴对卒中后肩手综合征的疗效与安全性。
- 主要结局为4周时疼痛视觉模拟评分和上肢体积差,随访至6个月。
核心结论
- 该试验旨在分析手法淋巴引流联合肌内效贴治疗卒中后肩手综合征在疼痛、肿胀和运动功能方面是否优于常规康复。
研究设计与样本
- 患者随机分为四组,每组24例:常规康复+肌内效贴、常规康复+手法淋巴引流、肌内效贴+手法淋巴引流、单纯常规康复。
- 所有参与者均接受常规康复作为基线干预,研究在位于中国西南地区的三级甲等医院 Army Specialized Medical Center 进行。
- 纳入标准为首次卒中、经CT和/或MRI诊断单侧肢体瘫痪并符合肩手综合征诊断标准的患者。
主要发现
- 原文未报告研究结果,仅报告研究方案。
关键数值与推荐
- 主要终点为干预4周时视觉模拟评分(VAS)疼痛强度和患侧与健侧上肢体积差。
- 次要终点包括上肢Fugl-Meyer评估(FMA-UE)、改良Barthel指数(MBI)、关节活动度(ROM)和卒中专用生活质量量表(SS-QOL)。
- 评估时间点为基线(T0)、干预开始后4周(T1)、治疗后3个月(T2)和6个月随访(T3)。
- 安全性通过监测治疗前后生命体征(血压和心率)、检查贴布应用部位皮肤完整性(如发红、皮疹)及记录患者报告的疼痛加重或其他不适来评估。
临床怎么用
- 该方案为卒中后肩手综合征的个性化康复治疗处方提供随机对照试验证据,尚待结果发表后指导临床决策。
局限性
- 原文未报告研究结果,无法评估干预的实际疗效和安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Shoulder-hand syndrome (SHS) is a common upper limb complication following stroke. It is associated with poor functional recovery of the upper limb and reduced mobility. Both kinesiology tape (KT) and manual lymphatic drainage (MLD) are considered effective interventions for treating pain and swelling associated with SHS. However, there is currently no research examining the limitations and safety profile of combining K-tape with MLD for SHS management. This study aims to investigate the efficacy of KT combined with MLD in patients with post-stroke shoulder-hand syndrome. METHODS: This study will be a prospective, single-center, randomized, factorial, controlled clinical trial. This exploratory randomized controlled trial aimed to investigate the efficacy of MLD combined with KT for post-stroke SHS. This study used a blinded design. Ninety-six patients with post-stroke SHS are randomly divided into four groups: (n = 24 per group): Experimental Group 1: Conventional Rehabilitation (CR) + KT, Experimental Group 2: Conventional Rehabilitation (CR) + MLD, Experimental Group 3 (EG3): KT + MLD, Control Group: CR alone. All participants will receive CR as the baseline intervention. All subjects are first‑ever stroke patients diagnosed with unilateral limb paralysis by CT and/or MRI and meet the diagnostic criteria for SHS. The informed consent process is carried out by a trained researcher not involved in the patients' clinical care in a private room. Therapists participating in this study must hold a rehabilitation therapist qualification. Unified training will be provided to the treating therapists on MLD, KT, and conventional rehabilitation techniques. This study is conducted at the Army Specialized Medical Center. The Army Specialized Medical Center is a tertiary Grade A hospital located in Southwest China. In China's hierarchical medical system, tertiary Grade A hospitals represent the highest level in the hospital classification system. Outcome measures will be assessed at four time points: baseline (T0), 4 weeks after initiating the intervention (T1), 3 months post-treatment (T2), 6-month follow-up (T3). The primary endpoints will be as follows: pain intensity measured by the Visual Analogue Scale (VAS) at T1, volume difference between the affected and unaffected upper limbs at T1. Secondary endpoints will include the following: upper limb motor function assessed by the Fugl-Meyer assessment for upper extremity (FMA-UE), activities of daily living evaluated using the modified Barthel index (MBI), joint range of motion (ROM) measurements, quality of life measured by the Stroke-specific quality of life scale (SS-QOL). Safety is assessed by monitoring vital signs (blood pressure and heart rate) before and after treatment, examining skin integrity at the tape application site for any adverse reactions (e.g., redness, rash), and recording any patient-reported increases in pain or other unexpected discomfort potentially related to the intervention. DISCUSSION: The efficacy of personalized rehabilitation therapy prescription interventions will be assessed through changes in primary and secondary outcome measures at the 4-week intervention point and during the 12-week follow-up period. To analyze whether MLD combined with KT for post-stroke shoulder-hand syndrome is superior to conventional rehabilitation in terms of pain, swelling, and motor function. TRIAL REGISTRATION: Clinical Trial Registry-China ChiCTR2300074140. https://www.chictr.org.cn/ . First submitted on 31 July 2023.
引用
- Yin L, Chang J, Gao S, et al. Effects of manual lymphatic drainage combined with Kinesio taping on post-stroke shoulder-hand syndrome: a study protocol for a randomized controlled trial in the Southwest China region. Trials. 2026. PMID: 42021349. doi:10.1186/s13063-026-09728-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。